Foreword (“New Targets and New Drugs: from in silico Planning to in vivo Testing”)

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 5, 2013-06 ,pp. : 475-476

Bentham Science Publishers

Access to resources Recommend Favorite

Drugs Polypharmacology by In Silico Methods: New Opportunities in Drug Discovery

By  

Current Pharmaceutical Design, Vol. 22, Iss. 21, 2016-06 ,pp. : 3073-3081

Bentham Science Publishers

Access to resources Recommend Favorite

The Inhibitory Effect of Some Drugs on Candida rugosa Lipase and Human Pancreatic Lipase: In vitro and In silico Studies

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 6, 2018-11 ,pp. : 602-609

Bentham Science Publishers

Access to resources Recommend Favorite

The Repurposing of Old Drugs or Unsuccessful Lead Compounds by in Silico Approaches: New Advances and Perspectives

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 19, 2016-08 ,pp. : 2088-2106

Bentham Science Publishers

Access to resources Recommend Favorite

New in silico and conventional in vitro approaches to advance HIV drug discovery and design

By Maga Giovanni   Veljkovic Nevena   Crespan Emmanuele   Spadari Silvio   Prljic Jelena   Perovic Vladimir   Glisic Sanja   Veljkovic Veljko  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 1, 2013-01 ,pp. : 83-92

Informa Healthcare

Access to resources Recommend Favorite